Aktie A2AS67 LOTUS BIO-TECHNOLOGY DEVELOPMENT CORP.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Lotus Bio-Technology Development Corp.

Aktien

A2AS67

US54570R1077

LBTD

Verzögert OTC Markets
Andere Börsenplätze
 19:04:43 10.08.2023 		% 5 Tage % 1. Jan.
0,01 USD -34,64 % Intraday Chart für Lotus Bio-Technology Development Corp. -.--% -.--%
2023 Lotus Bio-Technology Development Corp. (OTCPK:LBTD) übernahm Pioneer Digital Health, Inc. CI
2022 BioGnomics Lab, LLC hat Boomerangkit.com, LLC von Lotus Bio-Technology Development Corp. (OTCPK:LBTD) übernommen. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
Lotus Bio-Technology Development Corp. Increases Their Footprint in the Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Pioneer Digital Health
Lotus Bio-Technology Development Corp. acquired Pioneer Digital Health, Inc.
Lotus Bio-Technology Development Corp. announced that it has received $0.05 million in funding
Lotus Bio-Technology Development Corp. announced that it expects to receive $0.05 million in funding
Lotus Bio-Technology Development Corp. announces sale of Boomerangkit.com, LLC
BioGnomics Lab, LLC acquired Boomerangkit.com, LLC from Lotus Bio-Technology Development Corp..
Lotus Bio-Technology Development Corp. Releases Shareholder Update Addressing Securities and Exchange Commission's Complaint
Lotus Bio Technology Development : Current Report
Lotus Bio-Technology Development Corp, Inc. Initiates Company Name Change
Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Director and Surrendering of 150,000,000 Common Shares to Treasury.
Lotus Bio-Technology Development Corp, Inc , Announces Resignation of Zoltan Nagy as Director
Lotus Bio-Technology Development Corp. Announces YTD Revenues And Projections by The Newly Acquired Companies in The Digital Health And Wellness Home Testing Industry.
Lotus Bio-Technology Development Corp. Enters Fast-Growing Digital Health and Wellness Home Testing Markets with the Acquisition of Focal Point, Inc. and Boomerangkit.com, LLC.
Lotus Bio-Technology Development Corp. Appoints Hoyt Christopher as CEO
Lotus Bio-Technology Development Corp. acquired Boomerangkit.com, LLC/Focal Point, Inc. from Focal Point, Inc. and Boomerangkit.com, LLC.
Lotus Bio Technology Development : Attorney Letter with Respect to Current Information
Lotus Bio-Technology Development Corp. (OTC: LBTD) (“LBTD”) Announces Entering Into a Binding Letter of Intent
Lotus Bio-Technology Development Corp. entered into a binding letter of intent to acquire Little Jupiter Gold Project in Nevada, USA from AMT Industries Canada Inc.
Lotus Bio Technology Development : BIOTECH DEVELOPMENT CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATION. (form 10-Q/A)
Lotus Bio-Technology Development Corp. Reports Earnings Results for the Third Quarter Ended December 31, 2017
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2AS67 Aktie
  4. Nachrichten Lotus Bio-Technology Development Corp.
  5. Andere Sprachen